COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 844: Articles 8431-8440  | Next

Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV
Bessen, C., Plaza-Sirvent, C., Bhat, J., Marheinecke, C., Urlaub, D., Bonowitz, P., Busse, S., Schumann, S., Vidal Blanco, E., Skaletz-Rorowski, A., Brockmeyer, N., Overheu, O., Reinacher-Schick, A., Faissner, S., Watzl, C., Pfaender, S., Potthoff, A., Schmitz, I.
10.1101/2022.04.08.22273605 — Posted: 2022-04-10
Psychosocial predictors of COVID-19 vaccine uptake among pregnant women: a cross-sectional study in Greece
Galanis, P. A., Vraka, I., Katsiroumpa, A., Konstantakopoulou, O., Siskou, O., Zogaki, E., Kaitelidou, D.
10.1101/2022.04.06.22273526 — Posted: 2022-04-10
Outpatient and Home Pulmonary Rehabilitation Program Post COVID-19: A study protocol for clinical trial
Oliveira, L. V. F., Oliveira, M. C., Lino, M. E. M., Carrijo, M. M., Afonso, J. P. R., Moura, R. S., Galvao, L. S., Povoa, E. R. P., Oliveira, L. F. R. J., Reis, B. M., Diniz, R. H. C. O., Bernardes, R. R., Coutinho, J. C., Silva, A. S., Fonseca, D. R. P., Fonseca, A. L., Santos, D. B., Modesto, G. P., Maldaner, V. Z., Oliveira-Silva, I., Martins, R. A. B. L., Martins, P. S. L. L., Oliveira, C. S., Palma, R. K., Cipriano Junior, G., Vieira, R. P., Alves, L. R., Insalaco, G.
10.1101/2022.04.08.22273608 — Posted: 2022-04-10
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants
Emmenegger, M., Fiedler, S., Brugger, S. D., Devenish, S. R. A., Morgunov, A. S., Ilsley, A., Ricci, F., Malik, A. Y., Scheier, T., Batkitar, L., Madrigal, L., Rossi, M., Lynn, A. K., Saleh, L., von Eckardstein, A., Knowles, T. P. J., Aguzzi, A.
10.1101/2022.04.07.22273545 — Posted: 2022-04-10
Mortality in Switzerland in 2021
Locatelli, I., Rousson, V.
10.1101/2022.04.07.22273557 — Posted: 2022-04-10
Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals
Leiner, J., Pellissier, V., Hohenstein, S., Koenig, S., Schuler, E., Moeller, R., Nachtigall, I., Bonsignore, M., Hindricks, G., Kuhlen, R., BOLLMANN, A.
10.1101/2022.04.09.22273420 — Posted: 2022-04-10
NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses
Rydyznski Moderbacher, C., Kim, C., Mateus, J., Plested, J., Zhu, M., Cloney-Clark, S., Weiskopf, D., Sette, A., Fries, L., Glenn, G., Crotty, S.
10.1101/2022.04.08.487674 — Posted: 2022-04-08
SARS-CoV-2 and its variants, but not Omicron, induces thymic atrophy and impaired T cell development
Rizvi, Z. A., Sadhu, S., Dandotiya, J., Binayke, A., Sharma, P., Singh, V., Das, V., Khatri, R., Kumar, R., Samal, S., Kalia, M., Awasthi, A.
10.1101/2022.04.07.487556 — Posted: 2022-04-08
SARS-CoV-2 mutations affect proteasome processing to alter CD8+ T cell responses
Wellington, D., Yin, Z., Yu, Z., Heilig, R., Davis, S., Fischer, R., Felce, S. L., Hublitz, P., Beveridge, R., Dong, D., Liu, G., Yao, X., Peng, Y., Kessler, B. M. M., Dong, T.
10.1101/2022.04.08.487623 — Posted: 2022-04-08
Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike
Stalls, V., Lindenberger, J., Gobeil, S., Henderson, R., Parks, R., Barr, M., Deyton, M., Martin, M., Janowska, K., Huang, X., May, A., Speakman, M., Beaudoin, E., Edwards, R. J., Eaton, A., Montefiori, D., Williams, W., Saunders, K. O., Wiehe, K., Haynes, B. F., Acharya, P.
10.1101/2022.04.07.487528 — Posted: 2022-04-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).